2nd Quarter - Report
CSL BEHRING LLC for CSL BEHRING LLC
Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Preservation of the orphan drug tax credit Tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | Sr. Director, Healthcare Policy and External Affairs |
| JULIA GRANT New | Director, Healthcare Policy & Federal Affairs |
| DENNIS JACKMAN | Senior Vice President, Healthcare Policy & External Affairs |
Health Issues HCR
Preservation of the orphan drug tax credit due to the benefit in developing therapies for those with rare diseases. Patient protections regarding health care legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | Sr. Director, Healthcare Policy & External Affairs |
| JULIA GRANT | Director, Healthcare Policy & Federal Affairs |
| DENNIS JACKMAN | Senior Vice President, Healthcare Policy & External Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.